Related Experiment Video
Updated: Apr 26, 2026

12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
12.5K
Value of information analysis optimizing future trial design from a pilot study on catheter securement devices
Haitham W Tuffaha1, Heather Reynolds2, Louisa G Gordon3
1Griffith Health Institute, Griffith University, Gold Coast, QLD, Australia Centre for Applied Health Economics, School of Medicine, Griffith Health Institute, Griffith University, Meadowbrook, QLD, Australia haitham.tuffaha@griffith.edu.au.
Clinical Trials (London, England)
|August 3, 2014
Summary
Value of information analysis optimizes clinical trial design by maximizing research benefits. A four-arm trial with 220 patients per arm offers the highest return on investment for catheter securement devices.
Area of Science:
- Health economics
- Clinical trial design
- Biostatistics
Background:
- Value of information (VOI) analysis offers an alternative to traditional hypothesis testing for determining sample sizes in clinical trials.
- VOI analysis can optimize research design beyond sample size, including comparator arms and follow-up times.
- It focuses on maximizing the expected net benefit of research, balancing trial costs with the value of new information.
Purpose of the Study:
- To apply VOI methods to pilot study data on catheter securement devices.
- To determine the optimal design for a future, larger clinical trial.
Main Methods:
- Economic evaluation using data from a multi-arm randomized controlled pilot study.
- Comparison of four catheter securement devices: standard polyurethane, tissue adhesive, bordered polyurethane, and sutureless.
- Probabilistic Monte Carlo simulation to quantify uncertainty and calculate expected value of information.
- Estimation and comparison of expected costs and benefits for alternative trial designs.
Main Results:
- A randomized controlled trial on catheter securement devices is potentially valuable.
- A four-arm trial with 220 patients/arm maximizes expected net benefit (130% ROI).
- The standard hypothesis testing approach (388 patients/arm) yields lower net benefit (79% ROI).
Conclusions:
- VOI analysis enables efficient clinical trial design by maximizing expected net benefit.
- This approach should be integrated early in the design process for randomized clinical trials.
- Limitations include reliance on single pilot trial data and not evaluating varied follow-up durations.

